JOURNAL OF PRACTICAL HEPATOLOGY ›› 2018, Vol. 21 ›› Issue (3): 485-488.doi: 10.3969/j.issn.1672-5069.2018.03.049
Liu Honghong, Zhao Ping
Received:
2017-04-24
Online:
2018-05-10
Published:
2018-05-25
Liu Honghong, Zhao Ping. Insight of diagnosis and treatment of ascites in cirrhotics with integrated traditional Chinese and western medicine[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 485-488.
[1] 危北海,张万岱,陈治水,等. 肝硬化中西医结合诊治方案(草案). 2004,24(10):869-871. [2] Cattau EL,Benjamin SB,Knuff TE,et al.The accuracy of the physical examination in the diagnosis of suspected ascites. JAMA,1982,247:1164-1166. [3] Runyon BA.Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med,1986,146:2259-2261. [4] Webster ST,Brown KL,Lucey MR,et al.Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol,1996,91:366-368. [5] Runyon BA,Committee APG.Management of adult patients with ascites due to cirrhosis:an update. Hepatology,2009,49:2087-2107. [6] Perez AE,Perez TH.Power-an essential need for effective managers:Part III. Contemp Pharm Pract,1982,5:50-52. [7] Angeli P,Fasolato S,Mazza E,et al.Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis:Results of an open randomised clinical trial. Gut,2010,59(1):98-104. [8] Watson H,Jepsen P,Wong F,et al.Satavaptan treatment for ascites in patients with cirrhosis:A meta-analysis of effect on hepatic encephalopathy development. Metab Brain Dis,2013,28(2):301-305. [9] Akiyama S,Ikeda K,Sezaki H,et al.Therapeutic effects of short-and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis. Hepatol Res,2015,45:1062-1070. [10] Sakaida I,Kawazoe S,Kajimura K,et al.Tolvaptan for improvement of hepatic edema:A phase 3,multicenter,randomized,double-blind,placebo-controlled trial. Hepatol Res,2014,44(1):73-82. [11] Fukui H.Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites World J Gastroenterol,2015,21:11584-11596. [12] John S,Thuluvath PJ.Hyponatremia in cirrhosis:pathophysiology and management. World J Gastroenterol,2015,21:3197-3205. [13] Gentilini P,Casini-Raggi V,Di Fiore G,et al.Albumin improves the response to diuretics in patients with cirrhosis and ascites:results of a randomized,controlled trial. J Hepatol,1999,30:639-645. [14] Bernardi M,Caraceni P,Navickis RJ,et al.Albumin infusion in patients undergoing large-volume paracentesis:a meta-analysis of randomized trials. Hepatology,2012,55:1172-1181. [15] Sort P,Navasa M,Arroyo V,et al.Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med,1999,341:403-409. [16] Abraldes JG,Tarantino I,Turnes J,et al.Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology,2003,37:902-908. [17] Serste T,Melot C,Francoz C,et al.Deleterious effects of beta blockers on survival in patients with cirrhosis and refractory ascites. Hepatology,2010,52:1017-1022. [18] Singh V,Dhungana SP,Singh B,et al.Midodrine in patients with cirrhosis and refractory or recurrent ascites:a randomized pilot study. J Hepatol,2012,56:348-354. [19] Singh V,Dhungana SP,Singh B,et al.Midodrine in patients with cirrhosis and refractory or recurrent ascites:a randomized pilot study. J Hepatol,2012,56:348-354. [20] Bari K,Minano C,Shea M,et al.The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis. Clin Gastroenterol Hepatol,2012,10(10):1169-1175. [21] Fimiani B,Guardia DD,Puoti C,et al.The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function:a multicentric study. Eur J Intern Med,2011,22:587-590. [22] Gines P,Arroyo V,Quintero E,et al.Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology,1987,93:234-241. [23] Sanyal AJ,Genning C,Reddy KR,et al.The North American Study for the treatment of refractory ascites. Gastroenterology,2003,124:634-641. [24] Lai KN,Pun CO,Leung JW.Study of hepatic venous wedge and intraperitoneal pressures in cirrhotic patients with refractory ascites treated by dialytic ultrafiltration. J Gastroen Hepatol,1989,4(4):325-330. [25] Martin P,DiMartini A,Feng S,et al. Evaluation for liver transplantation in adults:2013 Practice Guidelines:by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology,2014,59(3):1144-1165. [26] 中国中西医结合学会消化疾病专业委员会,肝硬化腹水的中西医结合诊疗共识意见. 中国中西医结合杂志,2011,31(9):1171-1174. [27] 何润明,吕永慧. 泻下攻积、清热解毒类中药灌肠治疗肝硬化60例. 陕西中医,2009,30(9):1117-1118. [28] 谢绍武,何其发.自拟扶正消水敷脐方对肝硬化腹水的治疗作用.西药临床杂志,2010,22(1):50-51. [29] 徐文军,谢三英,周静,等. 神阙穴敷贴治疗肝炎肝硬化腹水的临床观察. 中国民间疗法,2004,12(8):15-18. [30] 鲍继奎,厉秀云,肖卫敏. 针刺透穴疗法治疗肝硬化腹水80例.陕西中医,2012,33(2):219-220. [31] Sakaida I,Kawazoe S,Kajimura K,et al.Tolvaptan for improvement of hepatic edema:A phase 3,multicenter,randomized,double-blind,placebo-controlled trial. Hepatol Res,2014,44(1):73-82. [32] John S,Thuluvath PJ.Hyponatremia in cirrhosis:pathophysiology and management. World J Gastroenterol,2015,21:3197-3205. [33] 贺平,李成杰,张紫寅,等. 不同直径PTFE覆膜支架在门脉高压TIPSS术中的应用效果. 海南医学,2013,24(19):2828-2831. [34] 高长秦,郭应兴.TIPSS术+食道胃底静脉曲张栓塞术前后门静脉压力的变化.中国现代医药杂志,2011,13(5):17-19. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||